Liraglutide 70748-0346-03

Package NDC

70748-0346-03

Manufacturer: Lupin Pharmaceuticals, Inc.
Dosage Form: Injection
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: October 2, 2025
Listing Expires: December 31, 2026
Application: ANDA215421

Need to source Liraglutide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Liraglutide	6 mg/mL

Drug Class

GLP-1 Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]Glucagon-Like Peptide 1 [CS]

Selected Package

70748-0346-03Selected

3 SYRINGE, PLASTIC in 1 CARTON (70748-346-03) / 3 mL in 1 SYRINGE, PLASTIC

Other packages for this product(1)

70748-0346-02

2 SYRINGE, PLASTIC in 1 CARTON (70748-346-02) / 3 mL in 1 SYRINGE, PLASTIC

View →